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Abstract
Background: Up to 70% of children with Attention-Deficit/Hyperactivity Disorder (ADHD) experience sleep
problems including difficulties initiating and maintaining sleep. Sleep problems in children with ADHD can result in
poorer child functioning, impacting on school attendance, daily functioning and behaviour, as well as parental
mental health and work attendance. The Sleeping Sound with ADHD trial aims to investigate the efficacy of a
behavioural sleep program in treating sleep problems experienced by children with ADHD. We have demonstrated
the feasibility and the acceptability of this treatment program in a pilot study.
Methods/Design: This randomised controlled trial (RCT) is being conducted with 198 children (aged between 5 to
12 years) with ADHD and moderate to severe sleep problems. Children are recruited from public and private
paediatric practices across the state of Victoria, Australia. Upon receiving informed written consent, families are
randomised to receive either the behavioural sleep intervention or usual care. The intervention consists of two
individual, face-to-face consultations and a follow-up phone call with a trained clinician (trainee consultant
paediatrician or psychologist), focusing on the assessment and management of child sleep problems. The primary
outcome is parent- and teacher-reported ADHD symptoms (ADHD Rating Scale IV). Secondary outcomes are child
sleep (actigraphy and parent report), behaviour, daily functioning, school attendance and working memory, as well
as parent mental health and work attendance. We are also assessing the impact of children’s psychiatric
comorbidity (measured using a structured diagnostic interview) on treatment outcome.
Discussion: To our knowledge, this is the first RCT of a behavioural intervention aiming to treat sleep problems in
children with ADHD. If effective, this program will provide a feasible non-pharmacological and acceptable
intervention improving child sleep and ADHD symptoms in this patient group.
Trial Registration: Current Controlled Trials ISRCTN68819261.
ISRCTN: ISRCTN68819261
Background
Attention-Deficit/Hyperactivity Disorder (ADHD) is one
of the most common developmental disorders in child-
hood, affecting approximately 5% of children and ado-
lescents [1]. ADHD is characterised by pervasive levels
of inattention, impulsivity and/or hyperactivity, resulting
in impairment in school and/or home settings [2]. In
addition to the symptomatic burden on the child and
consequences for families and schools, ADHD is asso-
ciated with huge financial costs. In the United States,
the estimated annual societal cost of ADHD in child-
hood and adolescence is US$42.5 billion [3]. The main-
stay of treatment for ADHD is stimulant medication.
However, concerns have been expressed about the
potential adverse effects of stimulant medication includ-
ing poor growth and cardiac effects [4]. Any strategies
which reduce the need for medication would therefore
be regarded as desirable [4]; identifying and managing
sleep problems might be one such strategy.
Sleep problems in children with ADHD - prevalence,
aetiology, and burden
Up to 70% of parents of children with ADHD report diffi-
culties with their child’s sleep [5], including difficulties initi-
ating and maintaining sleep [6-9]. A recent meta-analysis
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found that children with ADHD have higher rates of par-
ent-reported sleep problems than non-ADHD controls;
problems include bedtime resistance, sleep onset difficulties,
night awakenings and daytime sleepiness [10]. In addition,
children with ADHD have sleep problems when using
objective measures (e.g., polysomnography, actigraphy),
including greater sleep onset latency and poorer sleep effi-
ciency [10].
The cause of sleep problems in children with ADHD is
multi-factorial. Medication may play a role, since insom-
nia is a well-known side-effect of stimulant medication
[11] and bedtime refusal may be due to a rebound effect
when stimulant medication wears off [12]. However,
unmedicated children with ADHD also experience sleep
problems [7,9,13]. Comorbid disorders may also contri-
bute to sleep problems. Oppositional defiant disorder
(ODD) and conduct disorder (CD) may lead to bedtime
resistance [14-16], though at least one study has reported
that ODD was unrelated to sleep problems in children
with ADHD - this study reported that children with
comorbid internalising difficulties such as anxiety were at
a greater risk for sleep problems [17].
In 2006, we conducted a survey of 239 school-aged
children with ADHD investigating the burden of sleep
problems for these children [5]. Moderate/severe sleep
problems were reported by 45% of parents and asso-
ciated with significantly poorer child psychosocial qual-
ity of life using the Pediatric Quality of Life Inventory
(coefficient -11.95, 95% CI (-15.82 to -8.08)), daily func-
tioning using the Daily Parent Rating of Evening and
Morning Behaviour (coefficient -7.72, 95% CI (5.78 to
9.66)), caregiver depression/anxiety/stress using the
Depression Anxiety Stress Scale (odds ratio 3.15, 95% CI
(1.65 to 6.02)), and family functioning (all p ≤ 0.01). All
associations held after adjusting for confounders (medi-
cation use, comorbidities, child age, child gender, and
socioeconomic status). Importantly, when compared to
children without sleep problems, those with sleep pro-
blems were more likely to regularly miss (78 vs 54%) or
be late for school (58 vs 34%), and their caregivers were
more likely to be late to work (20% vs 4%).
Treating sleep problems in children with ADHD
The majority of sleep problems in children with ADHD
occur at or around sleep onset, and are behavioural in
origin [5]. Behavioural sleep problems are amenable to
intervention in the general population [18], and the
same may be true in children with ADHD. However no
controlled trials of behavioural sleep interventions have
been reported in children with ADHD. Only one small
study (n = 3) has evaluated behavioural interventions for
sleep problems in unmedicated children with ADHD
[19]. The intervention ran over five weeks using a writ-
ten manual, with weekly telephone follow-up after the
parent read each of the five chapters. Immediately fol-
lowing the intervention and at three months follow-up,
the severity of the child’s sleep problem decreased; the
children’s ADHD symptoms were unchanged.
Small, uncontrolled studies have evaluated the effects
of medication on sleep problems in children with ADHD.
The most common of these investigated the effects of
clonidine, an alpha-agonist which causes drowsiness. In a
chart review of 62 children and adolescents treated with
clonidine, 85% showed some improvement in time to fall
asleep, though one third of the sample experienced
adverse effects including morning sedation [20]. There
are significant concerns about accidental poisoning with
clonidine [21]. Melatonin is a hormone secreted by the
pineal gland soon after the onset of darkness. One open-
labelled and two randomised controlled studies have
examined the effectiveness of melatonin in the treatment
of sleep-onset insomnia in ADHD. These found some
effectiveness in reducing sleep onset latency [22,24], but
the studies were small (n = 24-27) and none led to
changes in the children’s ADHD symptoms.
It could be argued that sleep problems in children with
ADHD may be less amenable to change because of their
other challenging behaviours, but trials in children with
other challenging behaviours (ie learning disabilities and
autism) demonstrated that behavioural sleep interven-
tions can be effective [25-27]. If we could effectively man-
age sleep problems in children with ADHD then we may
be able to improve child ADHD symptoms, quality of life
and school attendance, as well as parent mental health
and work attendance. However, in our survey only 45%
of parents reported that their child’s treating paediatri-
cian had asked about the child’s sleep and, of these, only
60% reported receiving advice. Forty percent of parents
receiving advice reported that this was helpful [5].
In 2008, we developed a behavioural sleep intervention
program for children with ADHD and moderate/severe
sleep problems (n = 27). We evaluated the feasibility and
helpfulness of a brief (1 session) versus extended (2 to 3
session) behavioural sleep program and explored the
impact of each on child and family outcomes. At five
months, both brief and extended groups reported a
reduction in child sleep problems and ADHD symptoms
(both 67%). There was a trend towards improved child
psychosocial quality of life and daily functioning and par-
ental anxiety in the extended group only (Cohen’s d:
0.39, 0.47 and 0.50, respectively). Given the additional
improvement in child and family outcomes for children
in the extended group, we have selected this intervention
to test in a fully-powered randomised controlled trial.
Aims and hypotheses
We aim to conduct the first randomised controlled trial
of a behavioural sleep intervention in primary school
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aged children (5-12 years) with ADHD, in order to
determine whether managing sleep problems can effec-
tively improve ADHD symptoms, child sleep, and other
child and family outcomes. We hypothesise that, com-
pared to the control group, benefits of a behavioural
sleep intervention at 3, 6 and 12 months post-interven-
tion will include:
1. Improved child outcomes:
a. Lower proportion with sleep problems (parent
report).
b. Decreased sleep latency and increased sleep dura-
tion (actigraphy).
c. Lower (better) mean score on an ADHD symptom
scale, as reported by parents and teachers indepen-
dently (primary outcome).
d. Improved mean scores on continuous measures of
working memory, behaviour (parent and teacher
report), health-related quality of life, and school
attendance.
2. Improved primary caregiver outcomes:
a. Lower proportion of mental health problems as
measured on an adult mental health scale.
b. Improved mean scores on continuous measure of
work attendance.
Methods/Design
Overall study design
The Sleeping Sound with ADHD project is an RCT of a
behavioural sleep intervention versus usual care (see
Figure 1). The project runs from mid 2010 to the end of
2012. This period encompasses participant recruitment
(including determining eligibility for the study), baseline
data collection, intervention delivery and participant fol-
low-up (3-12 months). This project has been funded by
the National Health and Medical Research Council of
Australia (project grant number: 607362) and has been
granted ethics approval by the Royal Children’s Hospital
(#30033) and the Victorian Department of Education
and Early Childhood Development (#2010_000573)
Human Research Ethics Committees.
Participants
Participants include families of children aged 5 to 12
years with paediatrician diagnosed ADHD (any subtype)
and at least one of the following sleep problems: sleep
onset association disorder, limit setting disorder, delayed
sleep phase or insomnia (idiopathic or psychophysiologi-
cal), as defined by the American Academy of Sleep Medi-
cine (see below). Children are also eligible if they have
parent-reported night time anxiety (defined as having
both difficulties falling asleep and significant worry at
bedtime).
Recruitment - Stage 1
Victorian paediatricians (public and private) pre-identify
their patients with ADHD either through their medical soft-
ware (eg Genie, Medical Director) or through case notes.
Paediatricians send a study-designed letter to the child’s pri-
mary caregiver inviting them to take part in the study. The
letter advises parents that the research team will phone
them to ask about their child’s sleep and ADHD symptoms.
An ‘opt out’ approach is used, whereby parents are asked to
contact the study team if they do not wish to learn more
about the study. If parents do not opt out within a two
week period, the paediatrician provides the research team
with the contact details of the families by fax or post. The
team then contacts the parent to explain the study further.
In our 2006 survey, this approach resulted in a 74% uptake
rate and was well accepted by parents [5].
Recruitment - Stage 2
The research team telephones all parents who do not
opt out to assess inclusion/exclusion criteria (see section
below) and whether or not the parent is interested in
participating in the study (10 minute phone call). Eligi-
ble families are mailed an information sheet, consent
form, and baseline survey. To determine the extent of
any participant bias, data are collected and compared
with non-participants; this includes child gender, child
age, and socioeconomic status of the family’s immediate
neighbourhood.
Inclusion criteria
Eligible families include children who meet all of the fol-
lowing criteria:
a) Full diagnostic criteria for ADHD, using the 18-item
DSM ADHD Rating Scale IV, which is a validated
scale measuring the core symptoms of ADHD [28].
We also use study designed questions to assess ADHD
symptom duration (’Did your child have these symp-
toms for six months or longer before he/she was diag-
nosed with ADHD?), onset (’Did your child have these
symptoms before he/she turned seven?) and impair-
ment (Are these symptoms present at home, school or
when out socially e.g., in the park, visiting friends)?
b) Moderate/severe sleep problems by parent report [5].
c) American Academy of Sleep Medicine diagnostic
criteria for at least one sleep disorder including sleep
onset association disorder, limit setting disorder,
delayed sleep phase and/or insomnia (idiopathic or
psychophysiological) [29]. Children experiencing
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significant night time anxiety and difficulty falling
asleep at night are also eligible.
Exclusion criteria
Children are excluded from the study if they meet any
of the following criteria:
a) Receiving specialised help for their child’s sleep
from a psychologist or a specialised sleep clinic
(apart from their paediatrician).
b) Have a serious medical condition (e.g., severe cer-
ebral palsy) or an intellectual disability (IQ < 70).
Children with other developmental or mental health
comorbidities are not excluded.
c) Have suspected obstructive sleep apnoea (OSA).
OSA is assessed using the three OSA items from the
Child Sleep Habit’s Questionnaire (CSHQ) [30]. This
scale can help identify children who may suffer from
OSA. Parents who report that their child sometimes
or usually snores, stops breathing and/or snorts/
gasps during their sleep are contacted by the lead
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investigator (HH), a paediatrician, for further assess-
ment. If OSA is suspected, these children are
excluded and referred to appropriate clinical ser-
vices. After approximately six months, we will fol-
low-up with children excluded due to suspected
OSA to see whether they are eligible to participate
in the study following clinical assessment and possi-
ble treatment i.e. if they have ongoing behavioural
sleep problems despite treatment of their OSA.
Sample size
The primary outcome is ADHD symptom scores. In
order to detect a 0.4 standard deviation (clinically mean-
ingful) shift in the mean ADHD score between the
treatment and control group at the three-month follow-
up, with 80% power and at a significance level of 0.05,
we would require 99 children in each arm (198 total
children). Allowing for up to 20% reduction in the pro-
portion of children with sleep problems amongst the
control arm, this sample size would also ensure ade-
quate power to detect a further 20% reduction in the
proportion of children with sleep problems between the
intervention and control arms. It would also enable us
to detect a shift in other secondary outcomes, such as
the mean quality of life scores between the two treat-
ment arms.
In order to have follow-up data on 198 children at the
3 month follow-up, we need paediatricians to send
study information to approximately 1124 children with
ADHD. This assumes an initial 70% response rate (i.e.
consenting to hearing more about the study, n = 787),
and that of these, 45% will have a moderate/severe sleep
problems (based on 2006 survey [5], n = 354). This also
takes into account 70% of those with moderate/severe
sleep problems consenting to taking part in the study (n
= 248) and 20% participant drop out over the follow-up
period.
Randomisation
Upon receiving the completed consent form and base-
line survey, an independent research assistant rando-
mises families to either the behavioural sleep
intervention group or the control group of ‘usual care’.
Families are randomised using a pre-generated random
number sequence developed by a statistician, which is
contained in sealed opaque envelopes stored in the inde-
pendent research assistant’s office. We used varying
block sizes of 2, 4 and 6 in the randomisation sequence
to maintain balance between the trial arms over the
course of the trial and so that allocations could not be
predicted from the previous sequence. It is expected
that the patient group will predominantly be boys, so
that randomisation is stratified by gender in order for
distribution proportions of males and females to be
comparable across the randomisation groups. All
families are mailed a letter to inform them of their
group allocation. Intervention families are then tele-
phoned to book a consultation time at their paediatri-
cian’s office. Control families can access usual care for
ADHD from their child’s paediatrician - our previous
survey suggests this does not routinely involve sleep
management [5]. If the parent consented to teacher par-
ticipation, we mail the child’s teacher a baseline survey
to complete at the point of randomisation.
Intervention group
The behavioural intervention is evidence based [18] and
consists of two face-to-face, one-on-one sleep consulta-
tions with a trained clinician (trainee consultant paedia-
trician or psychologist) held two weeks apart and one
follow-up telephone call another two weeks later. The
first session focuses on an assessment of the child’s
sleep problem, providing information about normal
sleep and sleep cycles, advice about sleep hygiene, and a
plan specifically tailored to the child’s particular sleep
disorder. For example, sleep onset association disorder,
typically associated with the need for parental presence
at sleep time, is managed with adult fading (i.e., gradu-
ated extinction). This technique requires gradual with-
drawal of parental presence from the child’s bedroom
over 7-10 days. Limit setting disorder is managed by
ignoring child protests and rewarding compliance with
bedtime routines. Delayed sleep phase is managed by
temporarily setting the child’s bedtime later, gradually
bringing it forward, and waking the child at a pre-set
time in the morning and encouraging early morning
light exposure [18]. Parents are offered a range of man-
agement strategies and are free to choose the strategies
they would like to try. All parents are also asked to
complete a sleep diary. The second session is held two
weeks later to review the sleep diary, reinforce strategies,
trouble shoot and monitor progress.
A standardised consultation record is kept for all chil-
dren, as per our pilot. This includes the presenting sleep
problem/s, possible contributors to the problem (eg TV
in bedroom), ADHD medication use, comorbidities, and
usual bedtime routines. The clinician records the dura-
tion of each consultation, sleep problem diagnoses,
family sleep management goals, handouts given to par-
ents, and management strategies chosen by the family.
A follow-up telephone call is made at a time conveni-
ent for the family, approximately two weeks after the
second consultation, to provide an opportunity for the
child’s parents to ask further questions, and to reinforce
strategies, trouble shoot, and monitor progress.
Our pilot study demonstrated that this program is fea-
sible to deliver and acceptable to families. However, a
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barrier to participation was travel to the Royal Chil-
dren’s Hospital Melbourne and we have addressed this
by conducting consultations at the treating paediatri-
cian’s consulting rooms.
Measures
Data are collected using parent, teacher and self-report
questionnaires, as well as objective measures including a
face-to-face assessment of working memory and actigra-
phy - all measures are outlined in Table 1. Outcomes
are measured at 3, 6 and 12 months post randomisation
with the exception of actigraphy (3 months only), the
working memory test (6 months only) and teacher
report (3 and 6 months only).
Primary outcome
Child ADHD symptoms, using the ADHD Rating Scale
IV- parent and teacher versions. An 18-item validated
scale measuring the core symptoms of ADHD (inatten-
tion, impulsivity, hyperactivity), which has been demon-
strated to be sensitive to change [28].
Secondary outcomes
Child
Sleep problem - primary caregiver report of child sleep
problem (none, mild, moderate or severe) [5,31].
Children’s Sleep Habits Questionnaire (CSHQ) - 33-
item, validated measure of disorders of initiating and
maintaining sleep, which can distinguish clinical from
community samples [30].
Actigraphy - The Actiwatch 2 (Philips Resprionics) is a
small, motion sensor that is attached to the non dominant
wrist to measure body movements and is used to provide
an objective measure of sleep. Movement patterns are
analysed and used to differentiate between sleep and wake
times, thus providing an objective measure of sleep onset
and total sleep duration. Use of actigraphy data in children
has been shown to be reliable and valid and it also corre-
lates well with data obtained using polysomnography
(overnight observation of sleep) [32]. The Actiwatch is
accompanied by an instruction sheet and sleep log which
covers napping, medication use, time in bed, night awa-
kenings, morning awakening time etc. The sleep log assists
in the interpretation of Actiwatch data. Children wear the
Actiwatch for seven days during school term to assess
both weekday and weekend sleep behaviour.
Strengths and Difficulties Questionnaire (SDQ) - par-
ent and teacher versions. A 25-item validated measure
of behavioural and emotional problems for children
aged 4 to 16 years. It provides standard scores on 5 sub-
scales (hyperactivity/inattention, conduct problems,
emotional symptoms, peer relationship problems, and
prosocial behavior); a total problems score is derived
from the first 4 subscales [33].
Pediatric Quality of Life Inventory (PedsQL - child
and parent versions) - a 23-item validated measure for
children aged 2 to 18 years. Provides total, physical, and
psychosocial health summary scores, with higher scores
indicating better health-related quality of life [34].
School attendance - number of days missed or late for
school over the preceding three months [5].
Daily Parent Rating of Evening and Morning Beha-
viour (DREMB) scale - an 11-item rating of core ADHD
symptoms and behavioural problems typically experi-
enced over the past month [35].
Working Memory Test Battery for Children - a face-
to-face assessment which provides an objective measure
Table 1 Study measures and time-points
Measures Time point
Baseline 3 months 6 months 12 months
ADHD IV Rating Scale Parent ■ ■ ■ ■
Teacher ■ ■ ■
Moderate/severe sleep problem Parent ■ ■ ■ ■
Children’s Sleep Habits Questionnaire Parent ■ ■ ■ ■
Actiwatch 2 Child ■ ■
Strengths and Difficulties Questionnaire Parent ■ ■ ■ ■
Teacher ■ ■ ■
Pediatric Quality of Life Inventory Parent ■ ■ ■ ■
Child ■
School attendance Parent ■ ■ ■ ■
Working Memory Test Battery for Children Child ■
Other sleep help Parent ■ ■ ■
Sleep program evaluation (intervention only) Parent ■
Depression Anxiety Stress Scale Parent ■ ■ ■ ■
Work attendance Parent ■ ■ ■
Anxiety Disorders Interview Schedule for Children IV Parent ■
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of the impact of the sleep intervention on the child’s
working memory, a critical executive function. Back-
wards Digit Recall, Counting Recall, and Listening Recall
subtests are administered [36].
Other sleep help - parent report of other professional
help sought for their child’s sleep eg GP, school nurse.
Sleep program evaluation (intervention group only) -
parent report of the usefulness of program strategies
and ability to put strategies into practice.
Primary caregiver
Depression Anxiety Stress Scale (DASS) - a validated
21-item measure of adult mental health with clinical cut
points for each of the three subscales of depression,
anxiety and stress [37].
Work attendance - number of days missed or late for
work over the preceding three months [5].
Socio-demographic questions are also included in the
baseline questionnaire - these cover family composition,
parental education and age, language spoken at home,
annual household income, and child medication use and
diagnosed comorbidities.
A comprehensive assessment of comorbid diagnoses is
completed using the Anxiety Disorders Interview Sche-
dule for Children (ADIS-C-IV).38 This assessment is
conducted over the telephone shortly after randomisa-
tion (the ADIS-C-IV is validated for administration over
the telephone) [38]; assessing comorbidity is important
in understanding any differential effects of the interven-
tion as a result of the child’s comorbidity. We will also
assess inter-rater reliability to ensure consistency in the
way that interviewers code parental responses on the
ADIS-C. We will audio record the first 10 interviews of
parents who give verbal consent; interviewers will code
parental responses from these ten interviews and inter-
rater reliability coefficients will be calculated.
Data analysis
Analyses will be by ‘intention to treat’ at the level of the
individual child. At the 3, 6 and 12 month follow-up, we
will compare change in mean primary caregiver and teacher
scores (3 and 6 month follow-up only) on the ADHD Rat-
ing Scale IV between the two trial arms using t tests. We
will also compare proportions of children with moderate/
severe vs no/mild sleep problems between the two arms
using chi squared analysis at each of the follow-up periods.
We will compare mean scores at follow up for sleep latency
and duration (actigraphy), child working memory, beha-
viour, health-related quality of life, daily functioning and
school attendance, as well as compare mean number of
days late for work and parent mental health (depression,
anxiety and stress) between the two arms, using either
Mann-Whitney or t tests, as dictated by data distribution.
At each follow-up, we will conduct a set of regression
analyses (linear regression for continuous data, logistic
regression for categorical data) for each outcome,
adjusted for potential confounders identified a priori.
Confounders will include child age, medication use,
comorbidities, family socio-demographic factors, and
family socioeconomic status, which will be assigned
according to postal code of residence using the Index of
Relative Socioeconomic Disadvantage (mean 1000, s.d.
100) from the Australian Bureau of Statistics census-
based Socio-Economic Indexes for Areas (SEIFA) [39].
Discussion
ADHD is common and frequently associated with sleep
problems which are associated with poorer child and
family outcomes [5]. Despite the high prevalence of beha-
vioural sleep problems in children with ADHD, little
research has focused on their clinical management. This
study is the first RCT to investigate the efficacy of a beha-
vioural sleep intervention in children with ADHD and
moderate to severe sleep problems. We are investigating
whether or not treating sleep problems in this population
can improve ADHD symptoms and other child and family
outcomes such as child school attendance and parent
mental health. If this intervention is effective, we will be
able to take the next steps in the program’s evaluation and
translation i.e. an effectiveness trial in an existing work-
force. We have a mechanism to conduct such a trial in the
secondary care setting through our 380-member Austra-
lian Paediatric Research Network (APRN) [40]. Through
the APRN, child mental health services and the Royal Aus-
tralasian College of Physicians, we can effect the wider
translation of this program and its potential benefits to
children with ADHD and their families.
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